Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02028409
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
FAL![]() | (2R)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN- 2-OL | A | 1H01 | 0.7 | ![]() |
HDY![]() | 1-(DIMETHYLAMINO)-3-(4-{{4-(2-METHYLIMIDAZO[1,2- A]PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO}PHENOXY)PROPAN- 2-OL | A | 1OIR | 0.73 | ![]() |
H35![]() | N-(FURAN-2-YLMETHYL)-7H-PURIN-6- AMINE | A | 2UY5 | 0.87 | ![]() |
IHI![]() | 9-CYCLOPENTYL-6-[2-(3-IMIDAZOL- 1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE- 2-CARBONITRILE | A | 1U9W | 0.73 | ![]() |
BWP![]() | (2S)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN- 2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN- 2-OL | A | 1H08 | 0.72 | ![]() |
D3G![]() | (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE | A,B,C,D | 2FDW | 0.71 | ![]() |
PNU![]() | 6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN- 5-YL-ETHYLSULFANYL)-PYRIMIDIN-4- YLAMINE | A | 1IKX | 0.74 | ![]() |
LIE![]() | 2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)- 9-ISOPROPYL-9H-PURIN-8-AMINE | A | 2GTN | 0.71 | ![]() |
BI9![]() | 2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN- 4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)- N-METHYLBENZAMIDE | A | 2JKK | 0.73 | ![]() |
FRS![]() | 1-[5-methyl-2-(trifluoromethyl)furan- 3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4- triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)- 1,3-thiazol-2(3H)-ylidene]urea | A | 3DB6 | 0.72 | ![]() |
R78![]() | 4-{[(7R)-8-cyclopentyl-7-ethyl- 5-methyl-6-oxo-5,6,7,8-tetrahydropteridin- 2-yl]amino}-3-methoxy-N-(1-methylpiperidin- 4-yl)benzamide | A | 2RKU | 0.74 | ![]() |
92M![]() | 9-cyclopentyl-2-(4-(4-hydroxypiperidin- 1-yl)-2-methoxyphenylamino)-5-methyl- 8,9-dihydro-5H-pyrimido[4,5-b][1,4]diazepin- 6(7H)-one | A | 3H9F | 0.72 | ![]() |
IBI![]() | N-{trans-4-[4-(cyclopropylmethyl)piperazin- 1-yl]cyclohexyl}-4-{[(7R)-7-ethyl- 5-methyl-8-(1-methylethyl)-6-oxo- 5,6,7,8-tetrahydropteridin-2-yl]amino}- 3-methoxybenzamide | A | 3FC2 | 0.72 | ![]() |
207![]() | 1-AMINO-6-CYCLOHEX-3-ENYLMETHYLOXYPURINE | A | 1H0W | 0.71 | ![]() |
FBL![]() | (2S)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN- 2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN- 2-OL | A | 1H01 | 0.7 | ![]() |
D2G![]() | N-METHYL(5-(PYRIDIN-3-YL)FURAN- 2-YL)METHANAMINE | A,B,C,D | 2FDV | 0.72 | ![]() |
IHJ![]() | 9-CYCLOPENTYL-6-{2-[3-(4-METHYL- PIPERAZIN-1-YL)-PROPOXY]-PHENYLAMINO}- 9H-PURINE-2-CARBONITRILE | A | 1U9X | 0.72 | ![]() |
MR9![]() | 4-METHYL-3-({3-[2-(METHYLAMINO)PYRIMIDIN- 4-YL]PYRIDIN-2-YL}OXY)-N-[2-MORPHOLIN- 4-YL-5-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE | A,B | 2P4I | 0.71 | ![]() |
FCP![]() | (2R)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN- 4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN- 2-OL | A | 1H00 | 0.7 | ![]() |
BYP![]() | (2R)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN- 2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN- 2-OL | A | 1H08 | 0.72 | ![]() |
FAP![]() | (2S)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN- 4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN- 2-OL | A | 1H00 | 0.7 | ![]() |
608![]() | N-(4-phenoxyphenyl)-2-[(pyridin- 4-ylmethyl)amino]nicotinamide | A,B | 2P2I | 0.73 | ![]() |